Prices rise tomorrow. Last chance for best rate.
Mushroom boardroom: Why some execs are using psychedelics to get through the workday
This is a preview of a story that was initially published on our sister site, WorkLife, which covers the future of the workplace.
After his father died in 2018, Paul Marlow struggled with fear, anxiety and depression. That’s when he turned to microdosing psychedelics as a remedy — and he hasn’t looked back.
Microdosing, he said, helps him focus at work. As the pandemic persists, many who are looking for a jolt of motivation, inspiration or medication are turning to microdosing — that is, ingesting small amounts of psychedelic drugs to combat mental health issues and enhance creativity, productivity and physical well-being. Read the full story on WorkLife.
More in Marketing
Dentsu strikes Meta deal to build plumbing for mass influencer activation
Top CMOs are assembling armies of creators, but many lack the infrastructure required to get the most out of them. A deal between Dentsu and Meta aims to fix that problem.
“Brands recognize the cultural dominance of podcasts”: global podcaster Mel Robbins talks AI, ad budgets and audience ownership
The global podcaster sat down with Digiday during her first-ever Cannes Lions — an event she now knows holds real value.
Dollar Shave Club’s bet: AI makes agencies optional, not obsolete
Dollar Shave Club makes 90% of its advertising in-house. AI is coming for the other 10%.